AI assistant
Sending…
Inotiv, Inc. — Director's Dealing 2019
Dec 4, 2019
34595_dirs_2019-12-04_061bc04e-502a-462f-a5f7-83e0f5d5d7a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-12-02
Reporting Person: Sagartz John E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-02 | Common Shares | A | 8974 | — | Acquired | 630499 | Direct |
Footnotes
F1: Represents restricted grant subject to vesting and forfeiture.
F2: Of the 630,499 shares reported, 617,625 shares were previously reported as indirectly held. These shares were distributed to the reporting person as part of a pro-rata distribution from SW Chrysalis, LLC, of which the reporting person is the Co-President and Chief Strategy Officer.
More from Inotiv, Inc.
Capital/Financing Update
2026
Jun 3
Capital/Financing Update
2026
Jun 1
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 11
Capital/Financing Update
2026
May 5
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 10
Director's Dealing
2026
Feb 19